HC Wainwright Lowers Neurogene (NASDAQ:NGNE) Price Target to $50.00
Neurogene (NASDAQ:NGNE – Get Free Report) had its target price lowered by analysts at HC Wainwright from $55.00 to $50.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 209.79% from the company’s current price. Neurogene Price […]
